QuadMedicine is a company with a medical microneedle platform technology that can be applied broadly across transdermally deliverable vaccine pharmaceuticals, synthetic pharmaceuticals, and diagnostic medical devices. Compared to conventional subcutaneous injections or oral medications, the transdermal delivery enabled by QuadMedicine's microneedle platform technology offers advantages such as reduced side effects like gastrointestinal disorders, enhanced patient convenience, and faster drug delivery through high bioavailability.